Art
J-GLOBAL ID：201702262082504100   Reference number：17A0273240

悪性神経膠腫特異的抗がん剤の開発-endosomal escapeの効果

Author (2)：
SHIINO AKIHIKO

About SHIINO AKIHIKO

(滋賀医大 神経難病セ)

About 滋賀医大 神経難病セ

, 
TANIGAKI KENJI

About TANIGAKI KENJI

(滋賀県成人病セ 研)

About 滋賀県成人病セ 研


Material：
再生医療  (日本再生医療学会雑誌)

About 再生医療


Volume： 16  Issue： 増刊号  Page： 381  Publication year： Feb. 01, 2017 
JST Material Number： L2776B  ISSN： 1347-7919  Document type： Article
Article type： 会議録記事  Country of issue： Japan (JPN)  Language： JAPANESE (JA)
Thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
*glioma

About glioma

,...
Semi thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
*Malignant glioma

About Malignant glioma

,...
Register(free) or Log In to access 

Please login to MyJ-GLOBAL to see full information. You also need to select "Display abstract, etc. of medical articles" in your MyJ-GLOBAL account page in order to see abstracts, etc. of medical articles.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0273240&from=J-GLOBAL&jstjournalNo=L2776B") }}
JST classification (1)：
JST classification
Category name(code) classified by JST.
Basic research of antitumor(=antineoplastic)drugs 
(GW16010A)

About Basic research of antitumor(=antineoplastic)drugs

Substance index (1)：
Substance index
Chemical Substance indexed to the Article.
Geldanamycin

About Geldanamycin

Terms in the title (3)：
Terms in the title
Keywords automatically extracted from the title.
悪性神経膠腫

About 悪性神経膠腫

, 
抗がん剤

About 抗がん剤

, 
開発

About 開発


Return to Previous Page

TOP

BOTTOM